Axio BioPharma
A data platform that connects pharmaceutical manufacturers and their production partners while each organization keeps control of its own systems and records.
$2.4MPre-seed
Role not disclosedEP
Elmstead Partners
Activity from announced rounds
Activity in this selectionOct 24, 2026 · North America · Jan 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $3.4M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionAutoimmunity BioSolutions
Genetically guided therapies targeting elevated soluble IL7 receptor levels in autoimmune disease.
$1MSeed extension
Role not disclosed